PT-103: Retrospective case Control Study to Develop a Training Set for a Cross Validated Chemoresponse Marker Algorithm in Cases with Ovarian, Peritoneal or Fallopian Tube Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date5/6/10 → 4/30/11

Funding

  • Precision Therapeutics Incorporated: $9,250.00